← All stocks

iRhythm Holdings, Inc.

IRTC Net selling
CIK 0001388658 #1488 in the set updated 17 Sep 2026
Bought (120 mo)
$3.13M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$306.11M
$9.04M on a plan · $138.29M straight out of an exercise
Sold at will
$158.78M
186 of 440 sales
Net
−$302.98M
−$155.65M against sales at will

By person

40 insiders · 470 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Lathi Vijay K
Director
$425.00K (1)
$81.01M (20)
−$80.59M
1,405
0.0043%
$171.17K
King Kevin M
Director
$75.88M (46) scheduled
−$75.88M
250,422
0.7597%
$30.51M
Vort David A
Chief Commercial Officer
$39.84M (151) scheduled
−$39.84M
27,952
0.0848%
$3.41M
+306.3%
Blackford Quentin S.
President and CEO
$25.64M (20)
−$25.64M
226,008
0.6856%
$27.53M
+32,187%
Garrett Matthew C.
Chief Financial Officer
$13.23M (14) scheduled
−$13.23M
24,254
0.0736%
$2.95M
+1,843%
SYNERGY LIFE SCIENCE PARTNERS L P entity
10% owner
$13.10M (2)
−$13.10M
4,419,048
13.41%
$538.37M
+85.3%
Wilson Daniel G.
Chief Financial Officer
$8.57M (32)
−$8.57M
34,987
0.1061%
$4.26M
+52.4%
Patterson Chad
CHIEF COMM & PRODUCT OFFICER
$20.99K (1)
$7.50M (18)
−$7.48M
62,125
0.1885%
$7.57M
+9,714%
Murphy Patrick Michael
CBO and CLO
$6.80M (15)
−$6.80M
69,699
0.2114%
$8.49M
+340.8%
Day Mark J.
Chief Technology Officer
$6.79M (23)
−$6.79M
61,164
0.1856%
$7.45M
+50.7%
Scott Raymond W.
Director
$4.87M (7)
−$4.87M
5,046
0.0153%
$614.75K
−71.6%
Turakhia Minang
CHIEF MED/SCI OFCR EVP ADVTECH
$4.25M (12)
−$4.25M
60,116
0.1824%
$7.32M
+19,939%
Sung Derrick
EVP, Strat Corp Development
$4.25M (7) scheduled
−$4.25M
25,902
0.0786%
$3.16M
+780.7%
Shrishrimal Sumi
EVP, Chief Risk Officer
$3.78M (13)
−$3.78M
44,621
0.1354%
$5.44M
+247.1%
Devine Douglas
Chief Operating Officer
$2.83M (11)
−$2.83M
29,566
0.0897%
$3.60M
+5,652%
TALWALKAR ABHIJIT Y
Director
$557.76K (2)
$3.16M (17) scheduled
−$2.61M
21,872
0.0664%
$2.66M
+9,328%
Novo Holdings A/S entity
10% owner
$1.70M (1)
+$1.70M
2,124,448
6.44%
$258.82M
+12,397%
Smith Mervin
EVP Strategic Business Ops
$1.42M (9)
−$1.42M
22,410
0.0680%
$2.73M
+294.8%
Rosenbaum Marc Wade
Chief Accounting Officer
$1.09M (9)
−$1.09M
16,155
0.0490%
$1.97M
+184.6%
Bodaken Bruce G.
Director
$601.92K (2) scheduled
−$601.92K
14,211
0.0431%
$1.73M
+6,025%
Bairey Merz Cathleen Noel
Director
$513.55K (4)
−$513.55K
10,546
0.0320%
$1.28M
+4,446%
New Leaf Ventures II, L.P. entity
10% owner
$425.00K (1)
+$425.00K
1,741,589
5.28%
$212.18M
Bobzien Brice
Chief Financial Officer
$403.12K (3)
−$403.12K
24,428
0.0741%
$2.98M
+4,317%
Rodda Julianne
EVP, CHIEF PEOPLE OFFICER
$257.92K (1)
−$257.92K
18,201
0.0552%
$2.22M
−10.4%
Lawrence Brian Lee
Chief Technology Officer
$122.49K (1)
−$122.49K
20,154
0.0611%
$2.46M
Freeman Sean Clinton
EVP, Strategy & Corp Devt
$114.48K (1)
−$114.48K
13,641
0.0414%
$1.66M
SNYDERMAN RALPH
Director
$97.89K (2)
−$97.89K
13,288
0.0403%
$1.62M
+5,628%
Norwest Venture Partners XI, LP entity
10% owner
569,494
1.73%
$69.38M
Karti Karim
Former Chief Operating Officer
51,267
0.1555%
$6.25M
+2,359%
COYLE MICHAEL J
President and CEO
33,247
0.1009%
$4.05M
Fernandez Reyna M
EVP, Chief HR Officer
14,615
0.0443%
$1.78M
+15,284%
RUBASH MARK J
Director
13,788
0.0418%
$1.68M
+5,843%
Ling Karen
Director
11,141
0.0338%
$1.36M
+4,702%
YOOR BRIAN B
Director
7,171
0.0218%
$873.64K
BUDIG RENEE VARNI
Director
5,297
0.0161%
$645.33K
Patten Jason H
Director
4,436
0.0135%
$540.44K
+100.0%
Poul Mojdeh
Director
4,240
0.0129%
$516.56K
MCGINNIS KAREN K
Director
3,608
0.0109%
$439.56K
OBOYLE KEVIN C
Director
3,608
0.0109%
$439.56K
de Clercq Casper L.
Director
0
0.0000%
$0.00
Insider
Date
Role
Action
Shares
Price
Amount
Day Mark J.
3 Aug 2023
Chief Technology Officer
Exercised, kept
486
$36.22
$17.60K
King Kevin M
8 Apr 2021
Director
Exercised, kept
2,836
$35.25
$99.97K
Day Mark J.
23 Feb 2021
EVP, Research & Development
Exercised, kept
123
$63.95
$7.87K
Day Mark J.
23 Feb 2021
EVP, Research & Development
Exercised, kept
971
$36.22
$35.17K
Day Mark J.
23 Feb 2021
EVP, Research & Development
Exercised, kept
8,300
$17.00
$141.10K
Day Mark J.
31 Dec 2020
EVP, Research & Development
Exercised, kept
1,500
$17.00
$25.50K
Day Mark J.
31 Dec 2020
EVP, Research & Development
Exercised, kept
2,298
$8.18
$18.80K
Showing 250 of 470 transactions. The figures above use every one of them.

What was left out

Form 4 filings counted 420
Amendments (4/A) skipped 24
Filings about a different issuer 0
Unreadable filings 0
Joint filings 5
Sales on a Rule 10b5-1 plan 19
Sales straight out of an exercise 235
Sales at will 186
Transactions with no price 0
Shares from compensation/vesting 20,071,862
Sales filed before the plan box existed 87
History held since 21 Oct 2016